Merus to Participate in Upcoming Investor Conferences
Merus N.V. (MRUS) announced that its CEO will participate in investor conferences on February 7th and 22nd, 2024. The webcasts will be available on the company's website.
01/31/2024 - 08:00 AM
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics® ), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in a fireside chat at the following investor conferences:
Guggenheim 6th Annual Biotechnology Conference: Wednesday, February 7, 2024 at 2:30 p.m. ET Citi’s 2024 Oncology Leadership Summit: Thursday, February 22, 2024 at 9:00 a.m. ET The webcasts of the presentations will be contemporaneously available on the Investors page of the Company's website. Archived presentations will also be available there for a limited time after the event.
About Merus Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics® . Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website and twitter .
Multiclonics® , Biclonics® and Triclonics® are registered trademarks of Merus N.V.
When is Bill Lundberg, M.D., participating in the fireside chat?
Bill Lundberg, M.D. will participate in a fireside chat at the Guggenheim 6th Annual Biotechnology Conference on Wednesday, February 7, 2024, at 2:30 p.m. ET and at Citi’s 2024 Oncology Leadership Summit on Thursday, February 22, 2024, at 9:00 a.m. ET.
Where can the webcasts of the presentations be accessed?
The webcasts will be available on the Investors page of Merus N.V.'s website.
Will the archived presentations be available after the event?
Yes, the archived presentations will also be available on the Investors page of the Company's website for a limited time after the event.
MRUS Rankings
#2121 Ranked by Stock Gains
MRUS Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Netherlands
City
Utrecht
About MRUS
merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. our most advanced development programs use the biclonics® format. biclonics® are capable of simultaneously attacking tumors in multiple ways. for example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
